SCHEMBL98046

SCHEMBL98046

Cc1cc(C)c(C(=O)c2ccccc2P)c(C)c1

nearest known ligand 0.42

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.42
MEN1 O00255 2/20 0.42
HPGD P15428 2/20 0.41
LMNA P02545 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
MCOLN3 Q8TDD5 1/20 0.41
METAP2 P50579 1/20 0.39
HSD11B1 P28845 1/20 0.39
NFE2L2 Q16236 1/20 0.37
ABCB1 P08183 1/20 0.37
ALDH1A1 P00352 2/20 0.37
POLB P06746 1/20 0.37
CRHR1 P34998 1/20 0.36
AKR1C3 P42330 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7177456 0.98 KMT2A (0.41) KMT2AMEN1HPGDLMNASMN1; SMN2
SCHEMBL12002964 0.98 KMT2A (0.41) KMT2AMEN1HPGDLMNASMN1; SMN2
Ethyl Acetate SCHEMBL26093472 0.87 TSHR (0.41) KMT2AMEN1HPGDLMNASMN1; SMN2
SCHEMBL28258477 0.87 KMT2A (0.47) KMT2AMEN1HPGDLMNASMN1; SMN2
SCHEMBL247465 0.86 KMT2A (0.43) KMT2AMEN1HPGDLMNASMN1; SMN2
SCHEMBL28242774 0.85 KMT2A (0.46) KMT2AMEN1HPGDLMNASMN1; SMN2
SCHEMBL27845943 0.84 FABP4 (0.40) KMT2AMEN1HPGDLMNASMN1; SMN2
SCHEMBL7183628 0.84 CYP3A4 (0.42) KMT2AMEN1HPGDLMNAALDH1A1
SCHEMBL5472754 0.83 KMT2A (0.45) KMT2AMEN1HPGDLMNASMN1; SMN2
SCHEMBL7175276 0.81 ALDH1A1 (0.35) KMT2AMEN1HPGDLMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 155 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4370564-A1 COMPOSITION BASED ON (METH)ACRYLATE MONOMERS Bostik SA (FR) 2024-05-22 EP claimed
EP-4341306-A1 COMPOSITION BASED ON (METH)ACRYLATE MONOMERS Bostik SA (FR) 2024-03-27 EP claimed
WO-2024041271-A1 4D PRINTING TECHNOLOGY-BASED MULTI-RESPONSE VARIABLE-STRUCTURE WHEEL, AND VEHICLE 江苏大学 2024-02-29 WO claimed
CN-115820134-A Preparation method and application of full-lamination OCA (optically clear adhesive) 睿合科技有限公司 2023-03-21 CN claimed
WO-2022243629-A1 COMPOSITION BASED ON (METH)ACRYLATE MONOMERS BOSTIK SA (FR) 2022-11-24 WO claimed
CN-115260951-A Acrylate optical pressure-sensitive adhesive and preparation method thereof 江苏斯瑞达材料技术股份有限公司 2022-11-01 CN claimed
CN-111004587-B OCA optical adhesive tape and preparation method and application thereof 苏州赛伍应用技术股份有限公司 2022-06-17 CN claimed
CN-114561164-A Post-curable optical transparent adhesive tape and preparation method thereof 苏州赛伍应用技术股份有限公司 2022-05-31 CN claimed
CN-109810638-B Low-refractive-index optical pressure-sensitive adhesive and preparation method and application thereof 苏州凡赛特材料科技有限公司 2021-06-01 CN claimed
CN-112724890-A Adhesive film for antireflection film in laser projection system and preparation method thereof 苏州赛伍应用技术股份有限公司 2021-04-30 CN claimed
CN-112724889-A Low-temperature end-sealed optical adhesive for touch control film and use method thereof 苏州赛伍应用技术股份有限公司 2021-04-30 CN claimed
CN-109536087-B Optical pressure-sensitive adhesive and preparation method thereof 苏州凡赛特材料科技有限公司 2021-03-19 CN claimed
CN-111004587-A OCA optical adhesive tape and preparation method and application thereof 苏州赛伍应用技术股份有限公司 2020-04-14 CN claimed
CN-106675177-A Ultraviolet light-cured binding material, printing ink and preparation methods and application of ultraviolet light-cured binding material and printing ink 蚌埠金黄山凹版印刷有限公司 2017-05-17 CN claimed
CN-106470673-A Polymer formulations for nasolacrimal stimulation 奥库利维公司 2017-03-01 CN claimed
EP-1569979-B1 USE OF A MATERIAL FOR NOISE PROTECTION DEVICES, SWIMMING PROTECTION DEVICES, OTOPLASTICS AND FOR SECURING VENTINGS AND METHOD FOR THE PRODUCTION OF SAID PARTS DREVE OTOPLASTIK GMBH (DE) 2012-02-22 EP claimed
EP-1036829-B1 Ultraviolet curable coating compositions for cationic electrodeposition applicable to metallic materials and electrically conductive plastic materials SHIMIZU KK (JP) 2007-06-13 EP claimed
WO-2025094459-A1 METHOD FOR PRODUCING CURED PRODUCT, AND CURED PRODUCT 太陽ホールディングス株式会社 2025-05-08 WO disclosed
US-6399805-B2 SUCH AS LITHIUM 2,6-DIMETHYLBENZOYLPHENYLPHOSPHINE, USE AS PHOTOINITIATORS IN PHOTOCURABLE COMPOSITIONS SUCH AS FOR PHOTOGRAPHIC PRODUCTION OF RELIEF IMAGES CIBA SPECIALTY CHEMICALS CORPORATION 2002-06-04 US disclosed
US-20010031898-A1 Organometallic monoacylarylphosphines CIBA SPECIALTY CHEMICALS CORP. 2001-10-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010031898-A1 Organometallic monoacylarylphosphines NAF1, DHCR24, CBR1 KMT2A 956/4885MEN1 2263/4885HPGD 4041/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.